Curis (CRIS) Amortization of Deferred Charges (2013 - 2019)
Curis' (CRIS) quarterly Amortization of Deferred Charges came in at $8000.0 in Q1 2019, down 11.11% YoY from $9000.0 in Q1 2018, and down 20.0% on a QoQ basis from $10000.0 in Q4 2018.
Curis (CRIS) Amortization of Deferred Charges (2013 - 2019) Analysis & Trends
Curis (CRIS) has 7 years of Amortization of Deferred Charges data on file, last reported at $8000.0 in Q1 2019.
- Quarterly Amortization of Deferred Charges fell 11.11% year-over-year to $8000.0 in Q1 2019, while the trailing twelve-month figure through Dec 2019 was $8000.0 (down 77.14% YoY) and the FY2019 annual result came in at $8000.0, down 77.14% from the prior year.
- Amortization of Deferred Charges eased to $8000.0 in Q1 2019, from $10000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $119000.0 in Q1 2017 to a low of $7000.0 in Q3 2017.
- A 5-year average of $17117.6 and a median of $12000.0 in 2015 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2017 — Amortization of Deferred Charges jumped 891.67% — and 2018, when it sank 92.44%.
- Tracing CRIS's Amortization of Deferred Charges over 5 years: stood at $12000.0 in 2015, then changed by 0.0% to $12000.0 in 2016, then retreated by 25.0% to $9000.0 in 2017, then rose by 11.11% to $10000.0 in 2018, then slipped by 20.0% to $8000.0 in 2019.
- The last three Amortization of Deferred Charges figures came in at $8000.0 (Q1 2019), $10000.0 (Q4 2018), and $9000.0 (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 8,000.00 |
| Mar 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Dec 31, 2018 | 10,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Sep 30, 2018 | 9,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Jun 30, 2018 | 7,000.00 |
| Mar 31, 2018 | 9,000.00 |
| Mar 31, 2018 | 9,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Sep 30, 2017 | 7,000.00 |
| Jun 30, 2017 | 9,000.00 |
| Jun 30, 2017 | 9,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Mar 31, 2017 | 119,000.00 |
| Dec 31, 2016 | 12,000.00 |
| Dec 31, 2016 | 12,000.00 |